Mitral Regurgitation
TEER noninferior to surgery in patients with heart failure, mitral regurgitation
In patients with HF and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral valve surgery for efficacy and was linked with fewer safety endpoint events, according to data from the MATTERHORN trial.
MitraClip improves outcomes in patients with less severe mitral regurgitation, heart failure
Transcatheter mitral valve repair in addition to medical therapy led to a lower rate of CV events and hospitalizations and better health status compared with medical therapy alone for patients with HF and moderate to severe mitral regurgitation.
One-fourth of older adults with no history of CVD may have asymptomatic valvular disease
More than one-fourth of individuals aged 60 years or older with no history of heart disease may have asymptomatic valvular heart disease, according to a U.K. study published in the European Heart Journal – Cardiovascular Imaging.
Mitral regurgitation linked to heightened risk of CKD in patients with heart failure
LONG BEACH, Calif. — Patients with heart failure who also experienced mitral regurgitation saw a doubling of their creatinine, according to data presented here.
‘AI holds great promise’ in early diagnosis of rheumatic heart disease
Artificial intelligence may have a role in the early detection of rheumatic heart disease using mitral regurgitation jet analysis, according to study findings published in the Journal of the American Heart Association.
Sustained mitral regurgitation reduction for high-risk patients with Pascal system: CLASP IID
SAN FRANCISCO — Data show a novel transcatheter mitral valve edge-to-edge repair system was associated with a sustained reduction in mitral regurgitation plus functional and quality-of-life gains for patients at prohibitive surgical risk.
‘Spectacular results’ with next-gen TEER device for MR reduction, complications: EXPAND G4
SAN FRANCISCO — A fourth-generation mitral valve transcatheter edge-to-edge repair system was associated with durable reduction in mitral regurgitation severity to mild or less for most patients, including those with complex anatomy.
Transcatheter mitral valve repair system improves mitral regurgitation at 2 years
A transapical transcatheter mitral valve repair system was linked to extensive reduction in mitral regurgitation at 2 years in patients ineligible for surgery, researchers reported at TVT: The Structural Heart Summit.
Valve repair helps in HF, severe mitral regurgitation, even in patients with malnutrition
In patients with HF and severe secondary mitral regurgitation, transcatheter edge-to-edge mitral valve repair reduced mortality and HF hospitalization regardless of whether patients had malnutrition, new data from the COAPT trial show.
TEER safe, effective in high-surgical-risk patients with degenerative mitral regurgitation
NEW ORLEANS — An analysis of the STS/ACC TVT registry showed that successful transcatheter edge-to-edge repair for degenerative mitral regurgitation was safe and significantly improved symptoms and mortality at 1 year, a speaker reported.